Published in J Gene Med on January 01, 2009
In vivo gene delivery by nonviral vectors: overcoming hurdles? Mol Ther (2012) 1.59
The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials (2009) 1.37
Optical imaging-guided cancer therapy with fluorescent nanoparticles. J R Soc Interface (2009) 1.22
Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo. J Control Release (2013) 0.91
Scope of nanotechnology in ovarian cancer therapeutics. J Ovarian Res (2010) 0.85
Efficient hepatic delivery of drugs: novel strategies and their significance. Biomed Res Int (2013) 0.85
Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes. J Nanobiotechnology (2010) 0.79
Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are? World J Gastroenterol (2014) 0.75
Homo-Roche ester derivatives by asymmetric hydrogenation and organocatalysis. J Org Chem (2013) 0.75
Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies. Cancer Immunol Immunother (2013) 0.75
Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model. Small (2015) 0.75
Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment. Mol Ther Nucleic Acids (2016) 0.75
Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med (2008) 3.23
Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis (2010) 2.76
Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods (2008) 2.10
[Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project]. Med Clin (Barc) (2005) 1.78
Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain). J Acquir Immune Defic Syndr (2008) 1.68
Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery. Biomaterials (2012) 1.59
Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms. AIDS (2012) 1.55
Functional characterization of twelve natural PROS1 mutations associated with anticoagulant protein S deficiency. Haematologica (2008) 1.45
Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005. Enferm Infecc Microbiol Clin (2011) 1.43
Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more. BMC Infect Dis (2006) 1.23
Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol (2010) 1.12
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. Int J Epidemiol (2012) 1.11
Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery. Biomaterials (2012) 1.09
Adenosine-cannabinoid receptor interactions. Implications for striatal function. Br J Pharmacol (2010) 1.07
Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. J Biol Chem (2010) 1.02
Validation of the Spanish version of the Lawton IADL Scale for its application in elderly people. Health Qual Life Outcomes (2012) 1.01
Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. J Antimicrob Chemother (2009) 0.99
Adenosine A(2A) Receptors and A(2A) Receptor Heteromers as Key Players in Striatal Function. Front Neuroanat (2011) 0.93
G protein-coupled receptor heteromers as new targets for drug development. Prog Mol Biol Transl Sci (2010) 0.91
Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers. J Immunol (2009) 0.90
Cocaine disrupts histamine H3 receptor modulation of dopamine D1 receptor signaling: σ1-D1-H3 receptor complexes as key targets for reducing cocaine's effects. J Neurosci (2014) 0.90
Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal. Brain Res (2007) 0.87
A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes. Purinergic Signal (2013) 0.87
Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Eur J Pharm Biopharm (2006) 0.86
Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS). Antiviral Res (2010) 0.86
Post-translational membrane insertion of tail-anchored transmembrane EF-hand Ca2+ sensor calneurons requires the TRC40/Asna1 protein chaperone. J Biol Chem (2011) 0.85
In-hospital mortality after stomach cancer surgery in Spain and relationship with hospital volume of interventions. BMC Public Health (2009) 0.85
Calcium-mediated modulation of the quaternary structure and function of adenosine A2A-dopamine D2 receptor heteromers. Curr Opin Pharmacol (2009) 0.82
Waiting time for cataract extraction: Predictive factors and influence on outcomes. J Cataract Refract Surg (2010) 0.82
Intracellular calcium levels determine differential modulation of allosteric interactions within G protein-coupled receptor heteromers. Chem Biol (2014) 0.82
Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer. Biochem Biophys Res Commun (2010) 0.82
Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008-2010. Antivir Ther (2012) 0.81
Validation microsatellite path score in a population-based cohort of patients with colorectal cancer. J Clin Oncol (2011) 0.80
Targeted cationic poly(D,L-lactic-co-glycolic acid) nanoparticles for gene delivery to cultured cells. Cell Mol Biol Lett (2009) 0.79
Identification of recent HIV-1 infection among newly diagnosed cases in Catalonia, Spain (2006-08). Eur J Public Health (2011) 0.78
[Impact of a clinical self-evaluation intervention on the appropriateness of hospital stays]. Gac Sanit (2007) 0.78
Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia. Ann Hematol (2012) 0.78
A new D₂ dopamine receptor agonist allosterically modulates A(2A) adenosine receptor signalling by interacting with the A(2A)/D₂ receptor heteromer. Cell Signal (2011) 0.78
G-protein-coupled receptor heteromers as key players in the molecular architecture of the central nervous system. CNS Neurosci Ther (2014) 0.78
Retracted Modulation of GABA transport by adenosine A1R-A2AR heteromers, which are coupled to both Gs- and G(i/o)-proteins. J Neurosci (2011) 0.77
[Clinical and epidemiological study of a series of HIV-infected patients over 50 years old]. Enferm Infecc Microbiol Clin (2005) 0.76
[Early diagnosis of HIV infection]. Enferm Infecc Microbiol Clin (2012) 0.75
Variability in the prioritization of patients for cataract extraction. Int J Qual Health Care (2010) 0.75
Can an appropriateness evaluation tool be used to prioritize patients on a waiting list for cataract extraction? Health Policy (2009) 0.75
Appropriateness of phacoemulsification in Spain. Int J Qual Health Care (2009) 0.75
Effect of hospital on variation in visual acuity and vision-specific quality of life after cataract surgery. J Eval Clin Pract (2010) 0.75
Production of functional recombinant G-protein coupled receptors for heteromerization studies. J Neurosci Methods (2011) 0.75
[Compliance with antiretroviral treatment. Prevalence study in a general hospital]. Enferm Infecc Microbiol Clin (2003) 0.75